Berenbergs Chief Economist Warns ECB Rate Hikes Are a Big Mistake Amid Stagflation Fears
Meta Broadcom and Leading Chip Firms Launch 125 Million Semiconductor Research Hub at UCLA
Nvidia Posts Record Earnings But Shares Dip as Growth Concerns Mount
Best CD Rates Today May 27 2026 Yields Reach Up to 4 APY
I80 Gold Corp IAUX Highlighted as a Promising Gold Stock Under 5
Healthcare Leads Broad Market Advance as SP 500 Edges Higher
Root Inc ROOT Q1 2026 Earnings EPS Surges 1436 Above Estimates Revenue Data Not Disclosed
Haymaker Acquisition Corp 4 HYAC Q4 2025 Earnings Strong EPS Beat Driven by NonOperating Income Amid Business Combination Pursuit
O Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Environment
LUMN Q1 2026 Earnings Significant EPS Miss Reflects Ongoing Transformation Challenges
ORA Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Performance
Alight Inc Q1 2026 Earnings EPS Surprise Beats Estimates Stock Edges Higher
Texas Ventures Acquisition III Warrants TVACW Hold Steady at 051 as Key Levels Tighten
Dime Community Bancshares Preferred Stock Holds Steady at 1851 Amid Consolidation
Linkage Global Inc LGCB Holds Steady at 041 as Traders Eye Narrow Range
Zumiez Inc ZUMZ Surges 444 as Retail Sector Recovers Momentum
Morgan Stanley India Investment Fund IIF Rallies 135 as Emerging Market Sentiment Improves
Jobless Claims Drop to Lowest Level Since MidMay Signaling Labor Market Resilience
ANET Q1 2026 Earnings EPS Surpasses Estimates Shares Rise
iOThree Limited IOTR Declines 385 as Stock Tests Key Support at 19
SFL Q1 2026 Earnings Monumental EPS Surprise Overshadowed by Share Decline
CVR Partners UAN Q1 2026 Earnings Strong PerUnit Income Amid Steady Fertilizer Demand
BWIN Q1 2026 Earnings EPS Misses Estimates Amid Operating Headwinds
SPME Q1 2026 Earnings EPS Misses Estimates amid Portfolio Headwinds
Cytokinetics Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Takes Center Stage
FGBIP Q1 2026 Earnings EPS Surges 96 Above Estimates Stock Edges Lower
Serina Therapeutics Q1 2026 Earnings EPS Misses Estimates as Stock Climbs Despite Loss